Heartflow Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Heartflow Inc. Common Stock trades at $49.44 (market cap $4.38B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.5× Heartflow Inc. Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Heartflow Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| HTFL | RDY | |
|---|---|---|
Market Cap | $4.38B | $10.78B |
Volume | 1,454,420 | 2,724,343 |
Sector | Health | Health |
52-Week High | $52.21 | $15.38 |
52-Week Low | $20.49 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.24B | $10.68B |
Dividend Yield | — | 0.65% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →